Literature DB >> 16849486

B cells and CD4-CD8- T cells are key regulators of the severity of reactivation histoplasmosis.

Holly L Allen1, George S Deepe.   

Abstract

The fungus, Histoplasma capsulatum, produces a persistent infection. Reactivation histoplasmosis is largely a result of impaired immunity, but the perturbations associated with escape of the fungus from host defenses remain ill-defined. We analyzed a murine model of reactivation to elucidate the host defects that permit reactivation. C57BL/6 mice were infected intranasally and, 42 days later, they were depleted of CD4(+) and CD8(+) cells. Elimination of these cells, but not either alone, produced a persistent infection over several weeks. Neutralization of IFN-gamma, TNF-alpha, or both did not induce reactivation. Endogenous IL-10 exacerbated reactivation. Depletion of T cells in B cell(-/-) mice induced a markedly higher burden in organs when compared with wild type. However, the infection remained persistent. Elimination of CD4(+) cells alone or neutralization of cytokines increased the fungal load. The persistent infection was not dependent on gammadelta T cells or NK cells. Elimination of Thy-1.2(+) cells in mice given mAb to CD4 and CD8 transformed reactivation into a progressive, lethal infection in B cell(-/-) and wild-type mice, but the tempo of progression was accelerated in the former. The data reveal the complex control by the host to prevent reactivation of this fungus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849486     DOI: 10.4049/jimmunol.177.3.1763

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

2.  Genetic control of immune cell types in fungal disease.

Authors:  Jacob A Mayfield; Mary F Fontana; Jasper Rine
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

Review 3.  Histoplasma mechanisms of pathogenesis--one portfolio doesn't fit all.

Authors:  Jessica A Edwards; Chad A Rappleye
Journal:  FEMS Microbiol Lett       Date:  2011-08-09       Impact factor: 2.742

4.  Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum.

Authors:  Allan J Guimarães; Susana Frases; Francisco J Gomez; Rosely M Zancopé-Oliveira; Joshua D Nosanchuk
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

Review 5.  Histoplasma capsulatum at the host-pathogen interface.

Authors:  Joshua D Nosanchuk; Attila Gacser
Journal:  Microbes Infect       Date:  2008-07-10       Impact factor: 2.700

Review 6.  Histoplasma capsulatum, lung infection and immunity.

Authors:  Michael C Horwath; Roger A Fecher; George S Deepe
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

7.  Cryptococcus neoformans growth and protection from innate immunity are dependent on expression of a virulence-associated DEAD-box protein, Vad1.

Authors:  Jin Qiu; Michal A Olszewski; Peter R Williamson
Journal:  Infect Immun       Date:  2012-12-21       Impact factor: 3.441

Review 8.  Histoplasma Capsulatum: Mechanisms for Pathogenesis.

Authors:  Jamie Mittal; Maria G Ponce; Inessa Gendlina; Joshua D Nosanchuk
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

9.  The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum.

Authors:  Eszter Lázár-Molnár; Attila Gácser; Gordon J Freeman; Steven C Almo; Stanley G Nathenson; Joshua D Nosanchuk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

Review 10.  Treatment and Prevention of Histoplasmosis in Adults Living with HIV.

Authors:  David S McKinsey
Journal:  J Fungi (Basel)       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.